<b>Long-term Results After Primary Stenting of Distal Aortic Stenosis</b>

Ruppert, Volker; Wirth, Stéfan; Rieger, Johannes; Kueffer, Georg; Steckmeier, B.; Stoeckelhuber, Beate M.

doi:10.1583/05-1683mr.1

Cited by 11 publications

(3 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…9,17,18 After an aortic rupture in the beginning of our series, we reduced our post-ballooning diameter. Previous articles consider as target diameter the first aortic segment above the lesion "free from disease," instead of considering the hemodynamic necessity of the run-off.…”

Section: Discussionmentioning

confidence: 99%

Endovascular treatment as first line approach for infrarenal aortic occlusive disease

Schwindt

Panuccio

Donas

et al. 2011

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Endovascular treatment as first line approach for infrarenal aortic occlusive disease

Schwindt

Panuccio

Donas

et al. 2011

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

“…However, there are no studies comparing the long-term results of angioplasty to open surgery. Due to the rare occurrence of isolated disease of the infrarenal aorta, all series including the present study have small patient numbers, the most studies reporting only short-term results up to 48 months 11,20 (Table 4). Three main types of the major complications of the endovascular treatment are reported in the literature: aortic rupture, aortic dissection, and distal embolization.…”

Section: Discussionmentioning

confidence: 93%

Aortic Stenting in Symptomatic Infrarenal Aortic Stenosis and Subtotal Aortic Occlusion

Tatiana

Peter²,

Kempler³

et al. 2019

Vasc Endovascular Surg

View full text Add to dashboard Cite

Objective: The aim of this study was to evaluate the long-term results of aortic stent placement in patients with infrarenal aortic occlusive disease. Methods: Between April 1996 and May 2014, 34 patients with symptomatic infrarenal atherosclerotic aortic stenosis or subtotal aortic occlusion underwent percutaneous angioplasty with primary aortic stent implantation. There were 21 patients with Fontaine stage of the peripheral arterial disease (PAD) II, 5 patients with stage III, and 8 patients with stage IV. One patient withdrew informed consent and was excluded from further analysis. Results: Patients (n = 34, mean age: 62 ± 12 years) were followed for a mean period of 81 months. There were 2 procedure-related access-related complications. Six patients died during follow-up from non-procedure-related causes. Eight patients had late recurrence of symptoms during follow-up. Only in 2 cases, symptomatic recurrences were due to aortic in-stent stenosis (77 and 132 months after the primary stent implantation). Additionally, these 2 patients required therapy for PAD progression distal to the aorta. Five patients required further surgical or endovascular reconstruction for PAD progression distal to the aorta. In another case, clinical treatment failure was due to the progression of atherosclerotic lesion in the perirenal, nonstented part of the abdominal aorta. The mean estimated primary patency rate was 185.6 months (95% confidence interval: 161.3-209.8). Conclusion: Endovascular stent implantation is a safe and long-term effective strategy for the treatment of infrarenal aortic occlusive disease. In our study, the recurrence of symptoms was observed mainly due to atherosclerosis progression by multilevel disease with associated infrainguinal occlusive lesions but not to aortic in-stent restenosis. The prognostic advantage for this relatively young cohort of patients can be the possibility to repeat a percutaneous procedure with less technical difficulties when compared to surgical revision.

show abstract

“…The incidence of focal distal aortic stenosis without involvement of the aortic bifurcation is quite low so these lesions are usually reported in the literature along with stenosis involving the aortoiliac junction [7][8][9][10]. The incidence of isolated stenosis in the infrarenal aorta appears to be higher in young women, perhaps attributable to nicotine abuse [7,11,12]…”

Section: Introductionmentioning

confidence: 99%

Endovascular Treatment of Focal Infrarenal Aortic Stenosis with Absence of the Celiac Trunk - Case Report

Reis¹

2018

J Vasc Endovasc Surg

View full text Add to dashboard Cite

This case report describes a case of abdominal aortic stenotic disease treated with covered balloon-expandable stent with absence of the celiac trunk artery.Technique: Patients are selected for this strategy if they have a lesion without bifurcation involvement located at the mid segment of the infrarenal aorta or stenosis with unfavorable aortic anatomy, or severely diseased and calcified distal aorta. Conclusion:Our result in this case supports the feasibility, safety, and efficacy of stenting for stenosis of the distal infrarenal aorta.

show abstract

Long-term Results After Primary Stenting of Distal Aortic Stenosis

Abstract: In view of the excellent long-term results in our small series, primary stent placement in focal abdominal aortic stenosis in properly selected patients is a durable treatment. In addition, the mortality and morbidity risks are markedly reduced compared with open surgery.

Cited by 11 publications

References 28 publications

Endovascular treatment as first line approach for infrarenal aortic occlusive disease

Endovascular treatment as first line approach for infrarenal aortic occlusive disease

Aortic Stenting in Symptomatic Infrarenal Aortic Stenosis and Subtotal Aortic Occlusion

Endovascular Treatment of Focal Infrarenal Aortic Stenosis with Absence of the Celiac Trunk - Case Report

Contact Info

Product

Resources

About